GSE113853
ATACSeq - human CAR-T cells treated with lenalidomide
Genome-wide DNA accessibility maps of chromatin state in human CAR-T cells treated with lenalidomide in the presense or absense of Ag-specific restimulation Overall design: Anti-BCMA CAR T cells were cultured in the presence or absence of BCMA beads for either 24 hours or 7 days with or without 1 µM lenalidomide and subjected to ATACSeq